Quell Therapeutics is a biotechnology company developing engineered regulatory T-cell (nTreg) therapies for refractory autoimmune diseases
Quell Therapeutics is a biotechnology company developing engineered regulatory T-cell (nTreg) therapies for refractory autoimmune diseases. Its goal is to provide durable disease control through a single outpatient dose, while avoiding lymphodepletion and severe immune-related toxicities and building scalable manufacturing.